These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11580146)

  • 1. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma.
    Momoi H; Itoh T; Nozaki Y; Arima Y; Okabe H; Satoh S; Toda Y; Sakai E; Nakagawara K; Flemming P; Yamamoto M; Shimahara Y; Yamaoka Y; Fukumoto M
    J Hepatol; 2001 Aug; 35(2):235-44. PubMed ID: 11580146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.
    Furubo S; Harada K; Shimonishi T; Katayanagi K; Tsui W; Nakanuma Y
    Histopathology; 1999 Sep; 35(3):230-40. PubMed ID: 10469215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis.
    Limpaiboon T; Krissadarak K; Sripa B; Jearanaikoon P; Bhuhisawasdi V; Chau-in S; Romphruk A; Pairojkul C
    Cancer Lett; 2002 Jul; 181(2):215-22. PubMed ID: 12175538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
    Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
    Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features.
    Horie S; Endo K; Kawasaki H; Terada T
    Virchows Arch; 2000 Jul; 437(1):25-30. PubMed ID: 10963376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability in thorotrast-induced human intrahepatic cholangiocarcinoma.
    Liu D; Momoi H; Li L; Ishikawa Y; Fukumoto M
    Int J Cancer; 2002 Dec; 102(4):366-71. PubMed ID: 12402306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas.
    Della Torre G; Pasquini G; Pilotti S; Alasio L; Civelli E; Cozzi G; Milella M; Salvetti M; Pierotti MA; Severini A
    Diagn Mol Pathol; 2000 Mar; 9(1):41-6. PubMed ID: 10718212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.
    Liengswangwong U; Karalak A; Morishita Y; Noguchi M; Khuhaprema T; Srivatanakul P; Miwa M
    World J Gastroenterol; 2006 Jun; 12(23):3740-5. PubMed ID: 16773692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
    J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma.
    Limpaiboon T; Tapdara S; Jearanaikoon P; Sripa B; Bhudhisawasdi V
    World J Gastroenterol; 2006 Jul; 12(27):4377-82. PubMed ID: 16865781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.
    Boberg KM; Schrumpf E; Bergquist A; Broomé U; Pares A; Remotti H; Schjölberg A; Spurkland A; Clausen OP
    J Hepatol; 2000 Mar; 32(3):374-80. PubMed ID: 10735605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
    Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
    Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
    Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
    Abraham SC; Lee JH; Hruban RH; Argani P; Furth EE; Wu TT
    Hum Pathol; 2003 Sep; 34(9):902-10. PubMed ID: 14562286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations.
    Kim SJ; Akita M; Sung YN; Fujikura K; Lee JH; Hwang S; Yu E; Otani K; Hong SM; Zen Y
    Am J Surg Pathol; 2018 Apr; 42(4):512-521. PubMed ID: 29309301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.
    Liu XF; Zhang H; Zhu SG; Zhou XT; Su HL; Xu Z; Li SJ
    World J Gastroenterol; 2006 Aug; 12(29):4706-9. PubMed ID: 16937443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between genetic alterations and clinicopathological features in intrahepatic cholangiocarcinoma].
    Cong W; Finkelstein SD; Wu M
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):183-7. PubMed ID: 11866974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelotypic characteristics of thorotrast-induced intrahepatic cholangiocarcinoma: comparison to liver cancers not associated with thorotrast.
    Liu D; Wada I; Tateno H; Ogino D; Suzuki M; Li L; Lu W; Kojiro M; Fukayama M; Okabe H; Fukumoto M
    Radiat Res; 2004 Feb; 161(2):235-43. PubMed ID: 14731065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.